189 related articles for article (PubMed ID: 23900675)
1. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
Yu F; Miao J
Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
[TBL] [Abstract][Full Text] [Related]
2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
3. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.
Fan C; Zhao X; Xu Z
Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787
[TBL] [Abstract][Full Text] [Related]
4. The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer.
Yang M; Sun T; Zhou Y; Wang L; Liu L; Zhang X; Tang X; Zhou M; Kuang P; Tan W; Li H; Yuan Q; Yu D
Cancer; 2012 Oct; 118(19):4681-6. PubMed ID: 22359319
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D; Yang X; Li S; Liu T; Wu Z; Song Y; Wang J; Gao W; Huang Q; Huang W; Zheng W; Xiao J
Genet Test Mol Biomarkers; 2013 Jun; 17(6):458-63. PubMed ID: 23480667
[TBL] [Abstract][Full Text] [Related]
6. Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.
Zheng J; Yu X; Jiang L; Xiao M; Bai B; Lu J; Zhou Y
BMC Cancer; 2010 Oct; 10():522. PubMed ID: 20920330
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma.
Wang W; Wang J; Song H; Liu J; Song B; Cao X
Genet Test Mol Biomarkers; 2011; 15(7-8):503-6. PubMed ID: 21453059
[TBL] [Abstract][Full Text] [Related]
8. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
Chang WW; Zhang L; Yao YS; Su H
Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma.
Yang S; Wang C; Zhou Y; Sun G; Zhu D; Gao S
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1236-40. PubMed ID: 22905924
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
11. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
[TBL] [Abstract][Full Text] [Related]
12. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
13. Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto's thyroiditis susceptibility: a meta-analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Endocrine; 2014 Mar; 45(2):198-205. PubMed ID: 23677500
[TBL] [Abstract][Full Text] [Related]
14. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis.
Li G; Shi F; Liu J; Li Y
Diagn Pathol; 2014 Aug; 9():157. PubMed ID: 25128482
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.
Zhai JX; Zou LW; Zhang ZX; Fan WJ; Wang HY; Liu T; Ren Z; Dai RX; Ye D
Mol Biol Rep; 2013 Sep; 40(9):5213-23. PubMed ID: 23922195
[TBL] [Abstract][Full Text] [Related]
16. Current evidence on the cytotoxic T-lymphocyte antigen 4 + 49G > A polymorphism and digestive system cancer risks: a meta-analysis involving 11,923 subjects.
Xiaolei L; Baohong Y; Haipeng R; Shuzhen L; Jianfeng G; Xiangpo P; Haiyu L; Yuan Y; Dejie Z; Jinhong Y; Huanxin W; Wenhui W; Guohua Y
Meta Gene; 2015 Dec; 6():105-8. PubMed ID: 26629416
[TBL] [Abstract][Full Text] [Related]
17. Association between
Zhou C; Gao S; Yuan X; Shu Z; Li S; Sun X; Xiao J; Liu H
Aging (Albany NY); 2021 Aug; 13(15):19397-19414. PubMed ID: 34339393
[TBL] [Abstract][Full Text] [Related]
18. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
19. Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.
Yang J; Liu J; Chen Y; Tang W; Liu C; Sun Y; Chen J
Medicine (Baltimore); 2019 Jul; 98(29):e16266. PubMed ID: 31335675
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
Bilbao-Aldaiturriaga N; Patino-Garcia A; Martin-Guerrero I; Garcia-Orad A
Neoplasma; 2017; 64(2):299-304. PubMed ID: 28052683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
